Diagnosis and Management of Open-Angle Glaucoma
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 309
Special Issue Editors
Interests: new device glaucoma surgery; cataract surgery; medical retina; neuroophthalmology; artificial intelligence applications in opthalmology
Special Issues, Collections and Topics in MDPI journals
Interests: new device applications in ophthalmology; glaucoma surgery and medical glaucoma expert; cataract surgery; neuro-ophthalmology
Special Issue Information
Dear Colleagues,
Open-angle glaucoma is a condition with increasing prevalence worldwide; after cataracts, it is the main cause of visual impairment. The identification of the disease and its etiopathogenesis, as well as associated risk factors, leads to its early diagnosis and the reduction in the risk of progression at an important moment in the disease’s development. Open-angle glaucoma, especially secondary glaucoma, result in large variations in intraocular pressure and are painless, as well as leading to the significant progression of the disease and marked impairment of the quality of the patients' vision. Once diagnosed, modern innovations can be used in its management and to lead to the reduction in intraocular pressure, such as laser therapy or minimally invasive surgery. Gene therapy in glaucoma would also be a means of controlling the glaucomatous disease.
For this Special Issue, we request articles and reviews that include solutions related to the early diagnosis and treatment of glaucoma through new methods of diagnosis and treatment. The pandemic increased the appearance of advanced glaucoma due to the lack of medication and the continued need for treatment. The prediction of glaucoma progression via artificial intelligence tools has recently become a widely debated topic. Gene therapy in glaucoma would also be a means of controlling the glaucomatous disease.
Dr. Nicoleta Anton
Prof. Dr. Alina Popa-Cherecheanu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- open-angle glaucoma
- new technology
- artificial intelligence in ophthalmology
- gene therapy in glaucoma
- new device
